We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open17.78
High18.2
Low17.55
Prev. Close18.2
Avg. Traded Price17.8
Volume10,60,876

MARKET DEPTH

info2
Total bid3,18,953.00
Total ask4,47,515.00
OrdersQtyBid
2544117.55
1120017.54
245017.53
370117.52
21651117.51
AskQtyOrders
17.692660
17.71325
17.811
17.841500
17.851500

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

17.5517 minutes ago
18.204 hours ago
arrow

LOWER/UPPER CIRCUITS

17.29
19.11
arrow
Nectar Lifesciences Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteDebt to Equity Ratio,of 0.61 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 11.81%
Net profit growth 5Y CAGR : -36.3%
Nectar Lifesciences (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. NLL has transformed itself from being a small Domestic API player to one of the most integrated player in the Global Cephalosporins Industry within Anti Infective Therapeutic segment. NLL is catapulting itself into Cephalosporin Formulations in a defining way by entering lucrative regulated markets like US & European Union.
personal

Grow your wealth with more research recommendations

+91